Table 3.
Relationship between serum CEA or HMGB1 level and pathological characteristics in gastric cancer groups including EGC, AGC, and metastatic GC
Variables (γs) | CEA | P-value¶ | HMGB1 | P-value¶ |
Depth of invasion (T stage) | 0.118 | p > 0.05 | 0.273 | p = 0.011 |
Lymph node metastases (N stage) | 0.131 | p > 0.05 | 0.225 | p = 0.039 |
Pathological differentiation* | -0.040 | p > 0.05 | 0.009 | p > 0.05 |
Lymphovascular or perineural invasion | 0.105 | p > 0.05 | 0.067, | p > 0.05 |
Tumor location† | 0.037 | p > 0.05 | 0.041 | p > 0.05 |
Size of tumor‡ | 0.147 | p > 0.05 | 0.457 | P = 0.017 |
Stage§ | 0.098 | p > 0.05 | 0.221 | p = 0.040 |
*Gastric cancers are divided into intestinal and diffuse type carcinoma according to Lauren classification of differentiation.
†Gastric cancers are divided into three groups according to tumor location; antrum/body, cardia, diffuse.
‡Gastric cancers are divided into three groups by size; < 3 cm, 3–5 cm and > 5 cm.
§The stage of tumor was defined according to the UICC-TNM classification. Subjects with stage IV were excluded from this analysis.
¶ The relationship between each pathological variable and serum CEA or HMGB1 level in gastric cancer groups including EGC, AGC, and metastatic GC was evaluated by Spearman correlation (for non-continuous variables). γs, Spearman correlation coefficients.